Vanguard Capital Management’s Vivos Therapeutics VVOS Stock Holding History
Bought
Maintained
Sold
Other funds holding VVOS
Vanguard Capital Management's VVOS Position: Q3 2026 in Review
Vanguard Capital Management held its Vivos Therapeutics (VVOS) position steady in Q3 2026 at 60,629 shares worth $8.97K. The position accounts for ﹤0.01% of the portfolio, ranked #4022.
Vanguard Capital Management first reported a position in VVOS in Q1 2026 and has held it in 3 quarters since. The position peaked at $323K in Q1 2026. 27 funds tracked by Wall St. Rank hold VVOS as of Q3 2026.
- Vanguard Capital Management held 60,629 shares of Vivos Therapeutics worth $8.97K as of Q3 2026.
- Vanguard Capital Management left its Vivos Therapeutics share count unchanged in Q3 2026.
- Vivos Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4022 holding.
- Vanguard Capital Management first reported a position in Vivos Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Vivos Therapeutics position peaked at $323K in Q1 2026.
- 27 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.